Multistem®, a drug-like cell therapy to treat stroke with adult stem cells is developed by Athersys (ATH-er-sis), a clinical-stage biotechnology company founded by a group of leading scientists in 1995. In Episode 91, we...
At age 26, Paul Coyne had to leave Goldman Sachs because of the residual of the stroke that happened to him. Undeterred, Paul returned to school to prove that despite a very challenging stroke...
Sharon Thomas was a road construction worker in Oregon, whose life took an unexpected turn at age 45 when she collapsed with a massive stroke that left her unable to walk, talk or even...
Scott is the CEO of NEOFECT USA, and one of the founders of its parent company, NEOFECT. The med tech company creates gamified rehabilitation solutions for patients recovering from or living with stroke, dementia,...
Bob Mandell’s dedication to helping others stricken by stroke has led to a new career path as author, stroke coach, speaker, and founder of the Stroke Recovery Foundation, whose mission is to improve post-stroke...
No Guests in near future!
Episode 93 Multistem, A Game Changer – Interview With Gil Van Bokkelen, CEO of Athersys Dr Gil Van Bokkelen, Ph.D., CEO, Athersys, Inc Multistem®, a drug-like cell therapy to treat stroke with adult stem cells is developed by Athersys ...More
Episode 92: A Journey of Inspiration – Dr Paul Coyne and Inspiren At age 26, Paul Coyne had to leave Goldman Sachs because of the residual of the stroke that happened to him. Michael Wang, Co Founder of Inspiren and ...More
